Roxbury Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.2K Hold
53
– – 0.01% 326
2026
Q2
$11.1K Buy
53
+1
+2% +$196 0.01% 313
2026
Q1
$10.3K Hold
52
– – 0.01% 302
2025
Q4
$9.04K Hold
52
– – 0.01% 301
2025
Q3
$9.9K Hold
52
– – 0.01% 288
2025
Q2
$9.27K Buy
52
+1
+2% +$174 0.01% 285
2025
Q1
$8.88K Hold
51
– – 0.01% 280
2024
Q4
$8.32K Buy
+51
New +$7.93K 0.01% 309

Other funds holding DGX

Roxbury Financial's DGX Position: Q3 2026 in Review

Roxbury Financial held its Quest Diagnostics (DGX) position steady in Q3 2026 at 53 shares worth $12.2K. The position accounts for 0.01% of the portfolio, ranked #326.

Roxbury Financial first reported a position in DGX in Q4 2024 and has held it in 8 quarters since. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Roxbury Financial held 53 shares of Quest Diagnostics worth $12.2K as of Q3 2026.
  • Roxbury Financial left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.01% of Roxbury Financial's portfolio in Q3 2026, its #326 holding.
  • Roxbury Financial first reported a position in Quest Diagnostics in Q4 2024 and has held it in 8 quarters since.
  • 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Roxbury Financial's 13F filing for Q3 2026, filed 1 Oct 2026.